The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered...
from NDTV News - Special https://ift.tt/3eZbY7z
Subscribe to:
Post Comments (Atom)
AI boom drives global VC funding to record $300bn
Global venture funding surged to a record $300 billion in Q1, largely propelled by AI deals, with four companies securing a significant port...
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/mGFIOle
No comments:
Post a Comment